Literature DB >> 5082743

Carcinoma of the prostate: biopsy and conservative therapy.

R W Barnes, C A Ninan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5082743     DOI: 10.1016/s0022-5347(17)60901-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  9 in total

1.  Early (stage A) prostatic cancer. IV. Methodological criteria for histopathological diagnosis.

Authors:  S Battaglia; G Barbolini; A R Botticelli
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-06-29

2.  Patterns and management of urinary tract cancers among Nigerian Igbos.

Authors:  C Attah
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

3.  Texture analysis--a new method of differentiating prostatic carcinoma from prostatic hypertrophy.

Authors:  C Kratzik; E Schuster; A Hainz; W Kuber; G Lunglmayr
Journal:  Urol Res       Date:  1988

4.  Carcinoma of the prostate.

Authors:  G F Abercrombie
Journal:  Ann R Coll Surg Engl       Date:  1974-01       Impact factor: 1.891

5.  Early (stage A) prostatic cancer. VI. A critical look at the follow-up.

Authors:  S Battaglia; G Barbolini; A R Botticelli; G Berri; E Nigrisoli
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

Review 6.  Prostatic carcinoma: aspects of pathology, prognosis, and therapy.

Authors:  H Kastendieck
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

7.  Genitourinary malignancies.

Authors:  J G Connolly
Journal:  Can Fam Physician       Date:  1975-12       Impact factor: 3.275

8.  Adenocarcinoma of the prostate in perspective.

Authors:  A W Bruce; D E Mahan
Journal:  Can Med Assoc J       Date:  1978-11-04       Impact factor: 8.262

9.  The choice of estrogen preparations in the treatment of prostatic cancer.

Authors:  A Morales; B Pujari
Journal:  Can Med Assoc J       Date:  1975-11-08       Impact factor: 8.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.